Following recent U.S. Food and Drug Administration (FDA) approval 2, and in preparation for commercial launch in H1 2025, Telix has contracted with Cardinal Health to enable availability across a wide ...

Telix Pharmaceuticals Limited (ASX: TLX, NASDAQ: TLX, Telix, the Company) today announces that it has selected Cardinal Health ...

Castle Biosciences (CSTL) is supporting key educational programs and initiatives throughout the month of April in recognition of Esophageal ...

King Charles III and Queen Camilla met Italian President Sergio Mattarella on the second day of a state visit to Italy that ...

Opioid settlements with companies like Purdue Pharma, Walmart, and Johnson & Johnson have led to headline-grabbing ...

Researchers review how Food-as-Medicine (FAM) interventions can improve health, reduce healthcare costs, and reshape food ...

The Jellison family is the first major donor to former NBC correspondent Kristen Dahlgren's Cancer Vaccine Coalition.

DelveInsight's "TIBSOVO Market Size, Forecast, and Market Insight Report" highlights the details around TIBSOVO, the first ...

Exclusive: The 15th anniversary of LESFF will close with Lola Rocknrolla's true crime documentary "The Big Johnson" about ...

The agrichemical giant Bayer is lobbying for state and federal laws that would give it legal immunity from claims that ...

The book “Policing Show Business” shows how Trump’s attacks on “radical leftists” are like a sequel to the Red Scare.

Another company looking to initiate clinical trials with an epigenetic-editor-based treatment for hepatitis is nChroma Bio.